{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:43:53Z","timestamp":1792889033327,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsradet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.breast.2022.02.013","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T15:15:44Z","timestamp":1646147744000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3965-5568","authenticated-orcid":false,"given":"Matilda","family":"Appelgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Sackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Wengstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Ahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Bergkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Frisell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lundstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Sund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Vrou Offersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Filtenborg Tvedskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"de Boniface","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.breast.2022.02.013_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/bjs.10411","article-title":"Swedish Breast Cancer Group and the Swedish Society of Breast Surgery. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study","volume":"104","author":"de Boniface","year":"2017","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.breast.2022.02.013_bib2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.breast.2022.02.013_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","article-title":"Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study","volume":"251","author":"Veronesi","year":"2010","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.breast.2022.02.013_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.breast.2022.02.013_bib5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.breast.2022.02.013_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3361-y","article-title":"Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial","volume":"17","author":"de Boniface","year":"2017","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.breast.2022.02.013_bib7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.breast.2022.02.013_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment of the Axilla - surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2022.02.013_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J Surg Oncol"},{"issue":"32","key":"10.1016\/j.breast.2022.02.013_bib10","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1200\/JCO.2008.16.3766","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2022.02.013_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/bjs.9401","article-title":"Arm lymphoedema after axillary surgery in women with invasive breast cancer","volume":"101","author":"Sackey","year":"2014","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.breast.2022.02.013_bib12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1245\/s10434-016-5669-2","article-title":"Sentinel-lymph-node-based management or routine axillary clearance? Five-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial: assessment and incidence of true lymphedema","volume":"24","author":"Wetzig","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2022.02.013_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejso.2007.05.017","article-title":"Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial","volume":"34","author":"Del Bianco","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"25","key":"10.1016\/j.breast.2022.02.013_bib14","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.2010.28.2491","article-title":"Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: national Surgical Adjuvant Breast and Bowel Project phase III protocol B-32","volume":"28","author":"Land","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2022.02.013_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/02841860903302905","article-title":"Arm\/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life","volume":"49","author":"Nesvold","year":"2010","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.breast.2022.02.013_bib16","first-page":"1","article-title":"Return to work after breast cancer: the role of treatment-related side effects and potential impact on quality of life","volume":"28","author":"Schmidt","year":"2019","journal-title":"Eur J Cancer Care"},{"issue":"3","key":"10.1016\/j.breast.2022.02.013_bib17","first-page":"709","article-title":"Return to work among breast cancer survivors: a literature review","volume":"25","author":"Sun","year":"2017","journal-title":"Support Care Cancer"},{"issue":"13","key":"10.1016\/j.breast.2022.02.013_bib18","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1080\/09638288.2017.1300950","article-title":"Physical symptoms and working performance in female breast cancer survivors: a systematic review","volume":"40","author":"Zomkowski","year":"2018","journal-title":"Disabil Rehabil"},{"issue":"4","key":"10.1016\/j.breast.2022.02.013_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejso.2014.12.006","article-title":"Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery","volume":"41","author":"Sackey","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"24","key":"10.1016\/j.breast.2022.02.013_bib20","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2022.02.013_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.breast.2022.02.013_bib22","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","article-title":"The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study","volume":"14","author":"Sprangers","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2022.02.013_bib23","series-title":"The EORTC QLQ-C30 scoring manual","article-title":"Bottomley, A. On behalf of the EORTC quality of life group","author":"Fayers","year":"2001"},{"issue":"6","key":"10.1016\/j.breast.2022.02.013_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2522\/ptj.20100087","article-title":"Lymphoedema functioning, disability and health questionnaire (Lymph-ICF): reliability and validity","volume":"91","author":"Devoogdt","year":"2011","journal-title":"Phys Ther"},{"key":"10.1016\/j.breast.2022.02.013_bib25","series-title":"Klassifikation av funktionstillst\u00e5nd, funktionshinder och h\u00e4lsa","author":"Socialstyrelsen","year":"2003"},{"issue":"4","key":"10.1016\/j.breast.2022.02.013_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09593985.2018.1443186","article-title":"The Danish version of Lymphoedema Functioning, Disability and Health Questionnaire (Lymph-ICF) for breast cancer survivors: translation and cultural adaptation followed by validity and reliability testing","volume":"35","author":"Grarup","year":"2019","journal-title":"Physiother Theory Pract"},{"issue":"3","key":"10.1016\/j.breast.2022.02.013_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/lrb.2018.0025","article-title":"Revision of the lymphedema functioning, disability and health questionnaire for upper limb lymphedema (Lymph-ICF-UL): reliability and validity","volume":"17","author":"De Vrieze","year":"2019","journal-title":"Lymphatic Res Biol"},{"issue":"3","key":"10.1016\/j.breast.2022.02.013_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2022.02.013_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2648.1995.22030502.x","article-title":"Definitions of quality of life: a taxonomy","volume":"22","author":"Farquhar","year":"1995","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.breast.2022.02.013_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","article-title":"General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States","volume":"107","author":"Nolte","year":"2019","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.breast.2022.02.013_bib31","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: a theoretical model","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc Sci Med"},{"issue":"S8","key":"10.1016\/j.breast.2022.02.013_bib32","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/cncr.27467","article-title":"Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care","volume":"118","author":"Hayes","year":"2012","journal-title":"Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:43:40Z","timestamp":1760777020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977622000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"alternative-id":["S0960977622000406"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2022.02.013","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2022.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}